Trademark: 79403310
Word
CONSILIAS
Status Date
Thursday, September 5, 2024
Filing Date
Wednesday, January 10, 2024
41 Training in the operation and development of software systems; training relating to development in the field of cell and gene therapy; general training; training and further training consultancy; training sessions; training and instruction; personnel training; training courses; staff training services; business training.
9 Supply chain management software for cell and gene therapy and advanced therapies; software integration for supply chain management; software including medical and science; data management software for clinical trials; software for chain of identity and chain of custody management; application software for cloud computing services; software for the purpose of business and maintenance; software databases for the purposes of recording storage and processing of data; data storage apparatus; reporting software; software; cloud-based and cloud server; interactive business and database software; databases; training software; software for product development; artificial intelligence for analysis and reporting; artificial intelligence for healthcare.
35 Electronic data processing services including the collection of data for business purposes relating to health care information; computer database management services; data management services; data collection; data collection services; collection of data; commercial data analysis.
45 Software licensing for cell and gene therapy orchestration solution; software licensing to schedule and plan pharmaceutical resources; licensing of databases; granting of software licences to users.
42 Non-downloadable computer software in the medical sector including for cell and gene therapy orchestration; software as a service (SaaS) for business purposes; software as a service for cell and gene therapy orchestration; software as a services to schedule and plan pharmaceutical resources; software platforms for health data storage; control and tracking of cell and gene therapy products; software maintenance services; software as a service for management; control and tracking of cell and gene therapy products; platform as a service for cell and gene therapy orchestration; platform as a service to schedule and plan pharmaceutical resources; platform as a service for management; data as a service; software development services; consulting services in the field of software as a service; software customisation services; software for the purposes of consultancy and repair; platform software for business purposes; electronic data storage including data logs; online data storage services for the purposes of archiving databases; design and development of systems for data input, output, processing, display and storage; development of operating system software; software as a service featuring software for deep learning; technology consultation in the field of artificial intelligence; data authentication via blockchain; data storage via blockchain; validation and integrity of data via blockchain.
Aug 29, 2024
Sn Assigned For Sect 66a Appl From Ib
Sep 4, 2024
New Application Office Supplied Data Entered
Sep 4, 2024
Application Filing Receipt Mailed
Sep 5, 2024
Assigned To Examiner
Trademark Alertz updated from USPTO on 2030-01-24
